These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 27976597)

  • 1. Mycobacterial cell wall biosynthesis: a multifaceted antibiotic target.
    Abrahams KA; Besra GS
    Parasitology; 2018 Feb; 145(2):116-133. PubMed ID: 27976597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assembly of the Mycobacterial Cell Wall.
    Jankute M; Cox JA; Harrison J; Besra GS
    Annu Rev Microbiol; 2015; 69():405-23. PubMed ID: 26488279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Mycobacterial Cell Wall--Peptidoglycan and Arabinogalactan.
    Alderwick LJ; Harrison J; Lloyd GS; Birch HL
    Cold Spring Harb Perspect Med; 2015 Mar; 5(8):a021113. PubMed ID: 25818664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chapter 2: Biogenesis of the cell wall and other glycoconjugates of Mycobacterium tuberculosis.
    Kaur D; Guerin ME; Skovierová H; Brennan PJ; Jackson M
    Adv Appl Microbiol; 2009; 69():23-78. PubMed ID: 19729090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the formation of the cell wall core of M. tuberculosis.
    Barry CE; Crick DC; McNeil MR
    Infect Disord Drug Targets; 2007 Jun; 7(2):182-202. PubMed ID: 17970228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arabinogalactan and lipoarabinomannan biosynthesis: structure, biogenesis and their potential as drug targets.
    Jankute M; Grover S; Rana AK; Besra GS
    Future Microbiol; 2012 Jan; 7(1):129-47. PubMed ID: 22191451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure of mycobacteria to cell wall-inhibitory drugs decreases production of arabinoglycerolipid related to Mycolyl-arabinogalactan-peptidoglycan metabolism.
    Rombouts Y; Brust B; Ojha AK; Maes E; Coddeville B; Elass-Rochard E; Kremer L; Guerardel Y
    J Biol Chem; 2012 Mar; 287(14):11060-9. PubMed ID: 22315220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure, function and biosynthesis of the Mycobacterium tuberculosis cell wall: arabinogalactan and lipoarabinomannan assembly with a view to discovering new drug targets.
    Alderwick LJ; Birch HL; Mishra AK; Eggeling L; Besra GS
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):1325-8. PubMed ID: 17956343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lcp1 Is a Phosphotransferase Responsible for Ligating Arabinogalactan to Peptidoglycan in Mycobacterium tuberculosis.
    Harrison J; Lloyd G; Joe M; Lowary TL; Reynolds E; Walters-Morgan H; Bhatt A; Lovering A; Besra GS; Alderwick LJ
    mBio; 2016 Aug; 7(4):. PubMed ID: 27486192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterium tuberculosis proteins involved in mycolic acid synthesis and transport localize dynamically to the old growing pole and septum.
    Carel C; Nukdee K; Cantaloube S; Bonne M; Diagne CT; Laval F; Daffé M; Zerbib D
    PLoS One; 2014; 9(5):e97148. PubMed ID: 24817274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell wall: A versatile fountain of drug targets in Mycobacterium tuberculosis.
    Bhat ZS; Rather MA; Maqbool M; Lah HU; Yousuf SK; Ahmad Z
    Biomed Pharmacother; 2017 Nov; 95():1520-1534. PubMed ID: 28946393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of LytR-CpsA-Psr Proteins on Cell Wall Biosynthesis in Corynebacterium glutamicum.
    Baumgart M; Schubert K; Bramkamp M; Frunzke J
    J Bacteriol; 2016 Nov; 198(22):3045-3059. PubMed ID: 27551018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical Genetic Interaction Profiling Reveals Determinants of Intrinsic Antibiotic Resistance in Mycobacterium tuberculosis.
    Xu W; DeJesus MA; Rücker N; Engelhart CA; Wright MG; Healy C; Lin K; Wang R; Park SW; Ioerger TR; Schnappinger D; Ehrt S
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling the Structure of the Mycobacterial Envelope.
    Daffé M; Marrakchi H
    Microbiol Spectr; 2019 Jul; 7(4):. PubMed ID: 31267927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosynthesis of the arabinogalactan-peptidoglycan complex of Mycobacterium tuberculosis.
    Crick DC; Mahapatra S; Brennan PJ
    Glycobiology; 2001 Sep; 11(9):107R-118R. PubMed ID: 11555614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The thick waxy coat of mycobacteria, a protective layer against antibiotics and the host's immune system.
    Batt SM; Minnikin DE; Besra GS
    Biochem J; 2020 May; 477(10):1983-2006. PubMed ID: 32470138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring Targets of Cell Wall Protein Synthesis and Overexpression Mediated Drug Resistance for the Discovery of Potential M. tb Inhibitors.
    Nandi S; Saxena AK
    Curr Top Med Chem; 2021; 21(21):1922-1942. PubMed ID: 34315374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Drug Targets in Mycobacterial Cell Wall: Non-Lipid Perspective.
    Das S; Hameed S; Fatima Z
    Curr Drug Discov Technol; 2020; 17(2):147-153. PubMed ID: 29875004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.